Evidence map›Paper›PMID 40949135›Full record

ArticleFrontiers in pharmacology2025

Perception of falsified and counterfeit medicines among adults living in Mexico City and the metropolitan area: an underappreciated health risk.

Jessica Citlalli Celaya Pérez, Tania Ibargüengoitia Larios, Maria de Los Angeles Frías Fernández, Manuel Abraham Gómez Martínez, Kenneth Rubio Carrasco, Raúl Lugo Villegas, Arely Vergara-Castañeda

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jessica Citlalli Celaya PérezFacultad de Ciencias Químicas, Universidad La Salle México, Mexico City, Mexico.
Tania Ibargüengoitia LariosFacultad de Ciencias Químicas, Universidad La Salle México, Mexico City, Mexico.
Maria de Los Angeles Frías FernándezPrograma jóvenes a la investigación en matemáticas y ciencias experimentales. Escuela Nacional Colegio de Ciencias y Humanidades plantel Azcapotzalco, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Manuel Abraham Gómez MartínezDepartamento de Salud Pública, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Kenneth Rubio CarrascoFacultad de Ciencias Químicas, Universidad La Salle México, Mexico City, Mexico.
Raúl Lugo VillegasFacultad de Ciencias Químicas, Universidad La Salle México, Mexico City, Mexico.
Arely Vergara-CastañedaVicerrectoría de Investigación, Universidad La Salle México, Mexico City, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Falsified and counterfeit medicines represent a growing global public health concern and straddles business implications, and their proliferation has intensified worldwide. An analytical cross-sectional study was carried out to validate and assess the perception of a group of residents of Mexico City and the metropolitan area regarding the problem of falsified drugs and the risks they entail, along with the purchase of medicines at unauthorized points of sale. In addition, variables associated with buying or not buying at these points of sale were identified. The results suggest that even in a sample of mainly young adults, the potential exposition to collateral effects related to the consumption of falsified or counterfeit medicines is high. Although the participants recognized that these medicines are not safe, they are not familiar with the efforts or information of the corresponding authority to warn them of this problem. In addition, low awareness of the real implications of their nature and their possible impact on heath was identified, suggesting that the falsified and counterfeit medicines' market is a substantial and understudied issue among the Mexican population.

Indexed as

adultsepidemiologyfalsified drugshealth riskpharmacoepidemiologypublic health

Identifiers

PMID40949135
PMCPMC12426161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.